Browse

S-Space

Browsing by Author A002070]

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 95

Issue Date Title / Author(s) / CitationFileAltmetrics
1999-10
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
DOI
2005-06
Cytotoxic effects of pemetrexed in gastric cancer cells
link
2006-04
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
link
2006-09
Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells
2006-11
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007-04
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007-11
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view filelink
2008
Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Lee, Ju-Hee; Park, Jung-Hyun; Streb, Jeffrey W.; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue

International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2534-2543

link
2008-01
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
link
2008-01
Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin
DOI
2008-02
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008-03
Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells
link
2008-05
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
view filelink
2008-05
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2008-08
A-kinase anchoring protein 12 regulates the completion of cytokinesis

Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Park, Jung-Hyun; Kim, Hyun-Ah; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue

Biochemical and Biophysical Research Communications, Vol.373 No.1, pp.85-89

link
2008-09
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer
DOI
2008-11
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives
link
2008-11
DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1

Park, Jinah; Kim, Tae-You; Jung, Yeonjoo; Song, Sang-Hyun; Kim, Sung-Hak; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue

Journal of Molecular Medicine, Vol.86 No.11, pp.1269-1277

DOI
2008-12
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
view filelink
2008-12
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
link
2009-03
The role of PET/CT in detection of gastric cancer recurrence
view fileDOI
2009-05
Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deok; Yi, Hyeon Gyu; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Journal of Gastroenterology and Hepatology, Vol.24 No.5, pp.800-805

DOI
2009-07
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
DOI
2009-07
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
link
2009-08
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma
DOI
2009-08
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma

Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J.

Annals of Oncology, Vol.20 No.8, pp.1402-1407

DOI
2009-09
Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
DOI
2009-10
Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
view fileDOI
2010-02
Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity
DOI
2010-03
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
DOI
2010-05
Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer
DOI
2010-06
Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy
DOI
2010-06
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer
DOI
2010-08
Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy
view fileDOI
2010-12
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase
DOI
2011-03
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
view fileDOI
2011-03
Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer
DOI
2011-04
Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy

Kim, Ji-Won; Lee, Jeong-Ok; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

American Journal of Clinical Oncology, Vol.34 No.2, pp.125-129

DOI
2011-05
Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
DOI
2011-05
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
DOI
2011-06
Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization
DOI
2011-07
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
DOI
2011-07
Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study

Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175

DOI
2011-09
VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib
DOI
2011-09
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
DOI
2011-10
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
DOI
2011-10
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

Lim, Kyu-Hyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1017-1026

DOI
2012-02
Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer
DOI
2012-02
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy
DOI
2012-03
Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells
DOI
2012-04
The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen
2012-04
NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue

International Journal of Oncology, Vol.40 No.4, pp.1259-1266

DOI
2012-07
Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
DOI
2012-08
ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy
DOI
2012-08
Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer
DOI
2012-08
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer

Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue

Investigational New Drugs, Vol.30 No.4, pp.1404-1412

DOI
2012-11
The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use
DOI
2012-12
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines
DOI
2012-12
Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data
view fileDOI
1 2

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr youtube

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN